ENT Medical News about diabetes

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
OIG Seeks Revisions to the “Incident To” Rule

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Appropriate Antibiotic Use for Acute Otitis Media

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes
Otolaryngology Head and Neck Surgery, 10/27/09

Han CS et al. – ITSI is as effective as systemic steroid treatment for sudden SNHL patients with diabetes and it can avoid undesirable side effects. Therefore, it is considered ITSI to be a more reasonable alternative as an initial treatment for sudden SNHL patients with diabetes.

<< Previous
Prognostic value of Ki67 from clinically and histologically...

Next >>
The supernumerary nasal tooth